Unknown

Dataset Information

Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy.


ABSTRACT:

Background

Most lethal prostate cancers progress from relapse of aggressive primary disease. Recently, the most significant advances in survival benefit from systemic therapy have come from moving the administration of therapy to an earlier disease state. There is movement toward using biomarkers from the intraprostatic index lesion to guide early systemic therapy.

Objective

To determine the genomic heterogeneity, including the heterogeneity of predictive biomarkers, within the index focus of treatment-naïve prostate cancer.

Design, setting, and participants

Ten patients with treatment-naïve prostate cancer underwent prostatectomy. DNA was extracted from 70 spatially distinct regions of the 10 index foci.

Outcome measurements and statistical analysis

Single nuc

SUBMITTER: VanderWeele DJ 

PROVIDER: S-EPMC6586528 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature